Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Int. J. Mol. Sci. 2012, 13(9), 11923-11940; doi:10.3390/ijms130911923
Article

A Soluble Receptor for Advanced Glycation End-Products Inhibits Hypoxia/Reoxygenation-Induced Apoptosis in Rat Cardiomyocytes via the Mitochondrial Pathway

1,†,* , 2,†
, 1
, 1
, 2
, 1
, 1
 and 1
Received: 28 June 2012; in revised form: 5 September 2012 / Accepted: 11 September 2012 / Published: 20 September 2012
(This article belongs to the collection Programmed Cell Death and Apoptosis)
View Full-Text   |   Download PDF [2783 KB, uploaded 19 June 2014]
Abstract: Severe myocardial dysfunction and tissue damage resulting from ischemia/reperfusion (I/R) is a common clinical scenario in patients with certain types of heart diseases and therapies such as thrombolysis, percutaneous coronary intervention, coronary artery bypass grafting, and cardiac transplantation. The underlining mechanism of endogenous cardiac protection after I/R injury has been a focus of current research. Growing evidences suggests that soluble receptor for advanced glycation end-products (sRAGE) has a cardioprotective effect; however, its role in I/R injury remains unclear. We hypothesized that exogenous administration of sRAGE during hypoxia/reoxygenation (H/R) induces cardioprotection by inhibiting cardiomyocyte apoptosis via multiple signals, involving mitochondrial membrane potential (MMP), the mitochondrial permeability transition pore (mPTP), mitochondrial cytochrome c, caspase-3, Bcl-2 and Bax. Neonatal rat cardiomyocytes underwent hypoxia for 3-h followed by 2-h reoxygenation or were treated with sRAGE for 10 min before H/R. Compared with H/R alone, sRAGE pretreatment reduced H/R-induced cardiomyocyte apoptosis from 27.9% ± 5.9% to 9.4% ± 0.7% (p < 0.05). In addition, sRAGE treatment significantly inhibited H/R-induced mitochondrial depolarization and mPTP opening, reduced mitochondrial cytochrome c leakage, caspase-3 and caspase-9 activity, and decreased the ratio of Bax to Bcl-2. Therefore, we conclude that the exogenous administration of sRAGE during H/R is involved in cardioprotection by inhibiting apoptosis via the mitochondrial pathway, which, if further confirmed in vivo, may have important clinical implications during H/R.
Keywords: sRAGE; apoptosis; ischemia; reperfusion; mitochondria sRAGE; apoptosis; ischemia; reperfusion; mitochondria
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Guo, C.; Zeng, X.; Song, J.; Zhang, M.; Wang, H.; Xu, X.; Du, F.; Chen, B. A Soluble Receptor for Advanced Glycation End-Products Inhibits Hypoxia/Reoxygenation-Induced Apoptosis in Rat Cardiomyocytes via the Mitochondrial Pathway. Int. J. Mol. Sci. 2012, 13, 11923-11940.

AMA Style

Guo C, Zeng X, Song J, Zhang M, Wang H, Xu X, Du F, Chen B. A Soluble Receptor for Advanced Glycation End-Products Inhibits Hypoxia/Reoxygenation-Induced Apoptosis in Rat Cardiomyocytes via the Mitochondrial Pathway. International Journal of Molecular Sciences. 2012; 13(9):11923-11940.

Chicago/Turabian Style

Guo, Caixia; Zeng, Xiangjun; Song, Juanjuan; Zhang, Min; Wang, Hongxia; Xu, Xiaowei; Du, Fenghe; Chen, Buxing. 2012. "A Soluble Receptor for Advanced Glycation End-Products Inhibits Hypoxia/Reoxygenation-Induced Apoptosis in Rat Cardiomyocytes via the Mitochondrial Pathway." Int. J. Mol. Sci. 13, no. 9: 11923-11940.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert